MOLBIO DIAGNOSTICS LIMITED : INDIA BUSINESS EXCELLENCE FUND III DISPOSES 2.08% STAKE

• India Business Excellence Fund III, a scheme of Business Excellence Trust III, sold 23,77,627 equity shares of Molbio Diagnostics Limited on September 30, 2026. • The sale of 23,77,627 equity shares breaches the 2% threshold specified in Regulation 29(2) of the SEBI Takeover Regulations. • Post-sale holding is 78,99,123 equity shares, representing 6.85% of the total diluted share capital. • The transaction was conducted via an open market sale. • Impact: Negative (Significant disposal of shares by a large shareholder, potentially indicating a change in holding strategy.)

Molbio Diagnostics Ltd

Open attachment

← Back to feed